HAVCR2 and melanoma: However, the dynamic changes of Tim-3 on Treg cells in anti-PD-1 nonresponse melanoma patients, the potential cross-talk of PD-1 and Tim-3 in tumor-infiltrating lymphocytes (TILs), and the mechanism of the regulation of the two checkpoint receptors above have not been elucidated.